TipRanks
Celcuity (CELC)
NASDAQ:CELC
US Market
CELC
Celcuity
RESEARCH TOOLSreports
Want to see CELC full AI Analyst Report?

Celcuity (CELC) Stock News & Sentiment

557 Followers
Celcuity Files sNDA to Expand REVTORPYK Breast Cancer Use
Premium
Company Announcements
Celcuity Files sNDA to Expand REVTORPYK Breast Cancer Use
29d ago
8K
CELC
Celcuity Inc. Earnings Call: Revtopik Launch Set Stage
Premium
Company Announcements
Celcuity Inc. Earnings Call: Revtopik Launch Set Stage
1M ago
CELC
Celcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
Premium
Ratings
Celcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
1M ago
CELC
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
Premium
Ratings
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
1M ago
CELC
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
Premium
Ratings
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
1M ago
CELC
CELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
CELC
Celcuity: Buy Rating Reaffirmed on Gedatolisib’s Multi-Billion-Dollar Potential, $165 Price Target Unchanged
Premium
Ratings
Celcuity: Buy Rating Reaffirmed on Gedatolisib’s Multi-Billion-Dollar Potential, $165 Price Target Unchanged
2M ago
CELC
More CELC News >

CELC News on the Web

Celcuity Inc. at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral
Perceptive Advisors LLC Expands LeonaBio Inc (LONA) Stake in Strategic Add
GuruFocus News
Neutral
Celcuity (CELC): Landmark Approval Collides With A Costly Launch
Insider Monkey
Neutral
TANG CAPITAL MANAGEMENT LLC Buys Nano Dimension Ltd (NNDM) -- Shares Look 69% Undervalued on GF ...
GuruFocus News
Neutral
SILVERARC CAPITAL MANAGEMENT, LLC Trims Elutia Inc (ELUT) Stake -- Shares Look 11% Overvalued ...
GuruFocus News
Neutral
SilverArc Capital Management Exits KalVista Pharmaceuticals (KALV) Position Entirely
GuruFocus News
Neutral
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stake -- Shares Trade 55% Below GF Value
GuruFocus News
Neutral
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CELC’s Media Buzz Sentiment?
Currently, no data Available
What is CELC’s weekly average amount of articles?
In an average week, 2.5 articles about CELC are published.
    What is CELC’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    MRNAModerna
    ABEOAbeona Therapeutics
    ANABAnaptysBio
    VKTXViking Therapeutics
    AXSMAxsome Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week